Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
healthcare data - search results
If you're not happy with the results, please do another search
HealthTracker™ for patients, clinician & researchers
Professor Paramala Santosh, CEO of HealthTracker Ltd, co-developed the HealthTrackerTM platform – developed by clinicians, assisted by patients for patients, clinicians & researchers, more of which we learn about here.
Biosimilars: Improve access to treatment & reduce cost
Tore K Kvien & Guro L Goll argue that biosimilars are an opportunity for improving access to treatment & reducing cost and provide comment on the NOR-SWITCH study.
Creating a healthier post-coronavirus culture
Sue Johnson Gregory, principal consultant, and Tim Powlson, senior business consultant at Entec Si, explain how to build a stronger, more joined up workforce in the face of future healthcare crises.
Zebra Technologies: Dedicated to improving global health
We spoke with Tony Cecchin, Vice President and General Manager of Global Supplies at Zebra Technologies and President of Temptime Corporation, and Chris Caulfield, Vice President of Temptime Operations about their work supporting front-line workers and easing the shipment of medical products through the supply chain.
Africa: Strengthening public health surveillance systems
Several seasoned academic experts describe the move towards strengthening public health surveillance systems in Africa.
Curative approach to severe autoimmune diseases
Andrew Mackie, VP Business Development tells us how Imcyse, a Belgian immunotherapy expert, seeks a curative approach to severe autoimmune diseases.
Reconstructive Dentistry: New biomaterials & technologies
Mutlu Özcan, Prof. Dr Dr h.c., PhD from the University of Zürich, highlights Reconstructive Dentistry through new biomaterials and technologies, including the associated changes and challenges.
A simple prescription for healing chronic disease
Dr Shireen Kassam MBBS, FRCPath, PhD, dipIBLM, Founder and Director of Plant-Based Health Professionals UK, explains a simple prescription for health as a remedy to chronic disease.
The mind-body concept: From philosophy to clinical therapy
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, explains the mind-body concept, from a philosophical question to clinical therapy.
European Medicines Agency say AstraZeneca does not cause blood clots
The safety committee of the European Medicines Agency said the investigation did not prove that AstraZeneca vaccinations cause blood clots - describing the possibility as an "extremely small likelihood".
Innovation in chronic disease prevention
Dr Eugene Durenard, CEO of Hyperbolic Holdings GmbH discusses promising emerging technologies in the field of early detection and prevention of major chronic diseases.
How global evidence can improve outcomes for spinal patients
Everard Munting, President of EUROSPINE, explains why sharing knowledge about spinal treatments on a global scale is the most effective way to develop best practice and enable early interventions.
Digital Therapies: How have digital mental health treatments evolved?
Rosie Copland-Mann, Creative Strategist at Rehab, discusses how digital therapies for mental health treatment has evolved, with a special focus on COVID-19.
Italian approach to COVID-19: Dental industry perspective
Dr Ferruccio Berto, National Vice President and NLO for Foreign Affairs of the National Association of Italian Dentists, provides a dental industry perspective on the Italian approach to the COVID-19 pandemic.
Upskilling knowledge and training of diabetes management
A new medical education programme for diabetes healthcare providers in the UK is focusing on upskilling the knowledge and training of diabetes management technologies & devices.
Epilepsy research: Improving infrastructure & management
Arun Swaminathan MD, Assistant Professor of Neurology and Epilepsy at the University of Nebraska Medical Center, considers the importance of improving infrastructure and management of epilepsy research.
Bharat Biotech COVID vaccine shows 81% efficacy at Phase Three
The Bharat Biotech COVID vaccine, COVAXIN, appears to be 81% efficient against the virus in Phase Three of clinical trials.
Scientists find that elevated neutrophils can predict severe COVID and death
Researchers at Yale believe that blood tests could predict severe or critical COVID cases, because blood holds a series of interesting biological signals about a person.
Israel will now vaccinate Palestinians who have permits to work
Israel faced international criticism on their refusal to vaccine Palestinians - now, the country will begin rolling out Pfizer shots to some Palestinians who have work permits.
1.17 million doses of the AstraZeneca vaccine could expire in Germany
Germans have only taken 270,986 AstraZeneca doses so far, leaving roughly 1.17 million doses in storage across the country - but these shots are due to expire in less than six months.
